D

 

Neuroprotection by deprenyl and related compounds

Maruyama W, Naoi M

Department of Basic Gerontology,
National Institute for Longevity Sciences  Obu, Japan.
maruyama@nils.go.jp
Mech Ageing Dev 1999 Nov; 111(2-3):189-200

ABSTRACT

There is an increasing number of data by in vitro and in vivo experiments, indicating that (-)-deprenyl is neuroprotective to dopamine neurons, even though detailed mechanism remains to be clarified.  In this paper neuroprotection by (-)-deprenyl and structurally related compounds was examined in concern with the suppression of apoptosis induced by a reactive oxygen species, peroxynitrite generated from SIN-1.  The apoptotic DNA damage was quantitatively determined using dopaminergic SH-SYSY cells and by a single cell gel electrophoresis (comet) assay.  DNA damage induced by peroxynitrite was proved to be apoptotic by prevention of the damage by cycloheximide or actinomycin-D. (-)-Deprenyl and other propargylamines protected the cells from apoptosis in a dose-dependent way. (-)-Deprenyl protected the cells even after it was washed out, suggesting that it may initiate the intracellular process to repress the apoptotic death program.  The study on the structure-activity relationship of (-)-deprenyl analogues revealed that a N-propargyl residue with adequate size of hydrophobic structure is essentially required for the anti-apoptotic activity.  These results suggest that (-)-deprenyl and related compounds may protect neurons from apoptosis and be applicable to delay the deterioration of neurons during advancing ageing and in neurodegenerative disorders.

Vinpocetine  |  Idebenone  |  Galantamine  |  CDP Choline
Picamilon  |  Pyritinol  |  Modafinil  |  Piracetam

Order | Home       

Deprenyl Alzheimer's research                                                   www.deprenyl.info
       deprenyl   improves the performance of patients with Alzheimer's disease
       deprenyl   in the treatment of Alzheimer's disease
CDP Choline Alzheimer's research        !                                 www.cdpcholine.info
       CDP choline  may be useful in the treatment of Alzheimer's
       CDP choline  significant improvement after 1 month in early-onset Alzheimer's
       CDP choline  effects on cognition in patients with Alzheimer's
       CDP choline  significant improvement in Alzheimer's after 1 month  
       CDP choline  improved mental performance in Alzheimer's
Vinpocetine Alzheimer's research                  !                         www.vinpocetine.info
       vinpocetine  enhances oxygen release in vascular dementia  . 
       vinpocetine  article 
Piracetam Alzheimer's research                   !                            www.piracetam.info
       piracetam  improved alertness in Alzheimer's patients
       piracetam  improved cerebral glucose metabolism in Alzheimer's patients
       piracetam  use in Alzheimer's
       piracetam  therapy in Alzheimer's
       piracetam  a one year study of Alzheimer's patients 
       piracetam  article
Idebenone Alzheimer's research                      !                       www.idebenone.info
       Idebenone  versus Tacrine in Patients with Alzheimer's disease
       Idebenone  efficacy of idebenone in the treatment of Alzheimer's disease
       Idebenone  Nerve Growth Factor synthesis stimulators in Alzheimer's disease
       Idebenone  in the treatment of dementia of the Alzheimer type
       Idebenone  cognitive enhancement therapy for Alzheimer's disease
       Idebenone  study in the treatment of Alzheimer's disease
       Idebenone  two year study indicates idebenone slows Alzheimer's progression
       Idebenone  stimulates NGF synthesis in the treatment of Alzheimer's disease
       Idebenone  article
Pyritinol Alzheimer's research                          !                        www.pyritinol.info
       pyritinol  improved cognition in 100 dementia patients
       pyritinol  produced significant improvement in 40 dementia patients
       pyritinol  had therapeutic effect on 156 senile dementia patients
       pyritinol  improved cognitive performance in 26 dementia patients
       pyritinol  improved cerebral glucose metabolism in dementia
       pyritinol  article
 
.

Memantine Alzheimer's research                                              www.memantine.info

       Memantine  efficacy in patients with dementia
       Memantine  in senile dementia, Alzheimer type
       Memantine  and advanced dementia
       Memantine  for neuroprotection in dementia
       Memantine  in vascular dementia
       Memantine  in mild to moderate dementia
Galantamine Alzheimer's research                                            www.galantamine.cc
       galantamine  efficacy of galantamine in dementia and Alzheimer's disease
       galantamine  for Alzheimer's disease
       galantamine  novel approach to the treatment of Alzheimer disease
       galantamine  maintaining cognitive function in Alzheimer disease
       galantamine  maintaining functional abilities in Alzheimer disease
       galantamine  a new Alzheimer disease drug with a past life
       galantamine  treating vascular dementia with galantamine
       galantamine  rationale for switching from donepezil to galantamine
       galantamine  switching previous therapies for Alzheimer's disease to galantamine
       galantamine  its use in Alzheimer's
       galantamine  a new treatment for Alzheimer's
       galantamine  benefits to Alzheimer's patients
       galantamine  efficacy in mild to moderate Alzheimer's disease
       galantamine  effects on the course of Alzheimer's disease
       galantamine  a 5 month Alzheimer's study
       galantamine  effects in patients previously treated with donepezil
       galantamine  a six month Alzheimer's study
       galantamine  therapeutic effects beyond cognition in Alzheimer's disease
       galantamine  cognitive function in Alzheimer's disease
       galantamine  maintains cognitive function for at least 1 year
       galantamine  increase the density of brain nicotinic receptors
       galantamine  treatment for mild to moderate Alzheimer's disease.
       galantamine  may be effective as a cognition-enhancer in Alzheimer's disease
       galantamine  differs from other acetylcholine esterase inhibitors
       galantamine  safety and tolerability
       galantamine  dual mode of action for Alzheimer's disease
       galantamine  provides benefits for Alzheimer's for up to six months  .  
            article    Galantamine fights Alzheimer's
            article    Why galantamine is better than Aricept® and Exelon ®
            article    Galantamine can sharpen your mental edge
            article    Galantamine helps save memory
            article    Galantamine for combating mental decline
            article    Galantamine opens the channels of your memory
            article    Galantamine boosts memory
            article    Galantamine rescues brain cells
            article    Galantamine helps your memory
            article    Galantamine memory enhancement therapy
            article    Galantamine may help stave off dementia
            article    Galantamine enhances neurotransmission
            article    Galantamine increases acetylcholline
            article    Galantamine has benefits over Aricept®
 

 

 

Hit Counter